Michels, S., Massuti, B., Schildhaus, H., Franklin, J., Sebastian, M., Felip, E., . . . Wolf, J. (2019). Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial.
Citación estilo ChicagoMichels, S., et al. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial. 2019.
Cita MLAMichels, S., et al. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial. 2019.
Precaución: Estas citas no son 100% exactas.